Logotype for Comet Holding AG

Comet (COTN) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Comet Holding AG

H2 2025 earnings summary

6 Mar, 2026

Executive summary

  • Net sales grew 2.6% year-over-year to CHF 457.0 million, with 7.3% growth in constant currency, driven by semiconductor market recovery, new product traction, and advanced logic/AI infrastructure capex.

  • Profitability softened due to FX headwinds, upfront investments, and market volatility; EBITDA margin declined to 10.1% from 13.0% in FY24.

  • Strategic investments in products, platforms, and capacity, including high-volume Synertia orders and CA20 X-Ray System commercialization, position for the next semiconductor cycle.

  • Free cash flow dropped to CHF 8.5 million, reflecting higher capex for Penang and Flamatt facilities and Asian expansion.

  • Equity ratio stands at 61.6% with a net cash position of CHF 5.3 million and strong liquidity.

Financial highlights

  • Net sales: CHF 457.0 million, up 2.6% year-over-year (7.3% in constant currency).

  • Gross profit margin declined to 38% from 42.8% prior year, mainly due to FX and unfavorable mix.

  • EBITDA was CHF 46.3 million (10.1% margin), down from 13% margin in 2024.

  • Net income was CHF 12.2 million, down from CHF 32.8 million, impacted by deferred tax asset changes and FX.

  • CapEx rose to CHF 42.5 million (9.3% of sales), mainly for Penang and Flamatt facilities.

  • Free cash flow remained positive at CHF 8.5 million.

  • Net cash position of CHF 5.3 million and nearly CHF 100 million in cash and equivalents.

  • Dividend per share reduced to CHF 0.50 (31.9% payout ratio).

Outlook and guidance

  • Net sales and adjusted EBITDA margin for 2026 expected to significantly exceed 2025, excluding one-off costs of ~3 percentage points for Penang ramp-up and efficiency program.

  • Semiconductor market outlook is bullish for 2026, with wafer fab equipment spend expected to grow 10–20% year-over-year.

  • Strong order intake anticipated in Q1/26, with book-to-bill ratio notably above 1.

  • Strategic targets for 2030: CHF 670–770 million net sales, 22–27% EBITDA margin, 27–32% ROCE.

  • No quantitative guidance provided for 2025 due to ongoing market volatility and limited visibility.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more